Compare LyondellBasell Industries NV (LYB) vs Twist Bioscience Corp (TWST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
LyondellBasell Industries NV vs Twist Bioscience Corp — how do they compare? LyondellBasell Industries NV trades at $63.98 (market cap $20.67B), while Twist Bioscience Corp trades at $124 (market cap $7.72B). The key difference: LyondellBasell Industries NV is far larger — about 2.7× Twist Bioscience Corp's market cap, and LyondellBasell Industries NV pays a 6.44% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| LYB | TWST | |
|---|---|---|
Market Cap | $20.67B | $7.72B |
Sector | Basic Materials | Health |
52-Week High | $82.38 | $124.88 |
52-Week Low | $42.28 | $24.16 |
Enterprise Value | $32.26B | $7.65B |
Dividend Yield | 6.44% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About LyondellBasell Industries NV
LyondellBasell Industries NV is a petrochemical producer with operations in the U.S. and Europe. It operates in six segments: Olefins and Polyolefins-Americas (O&P-Americas), Olefins and Polyolefins-Europe, Asia, International (O&P-EAI), Intermediates and Derivatives (I&D), Advanced Polymer Solutions (APS), Refining and Technology. The company is a major producer of polyethylene, the world's largest producer of polypropylene, and the second- largest producer of propylene oxide. Its chemicals are used in various consumer and industrial end products. Substantially, all of the company's revenue is derived from product sales.
Read more on LYB →About Twist Bioscience Corp
Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →
